Mint-Quetiapine XR 150 mg (Quetiapine (Quetiapine Fumarate) TABLET (EXTENDED-RELEASE)) 150 MG

Mint-Quetiapine XR 150 mg is an extended-release tablet used for managing certain mental health conditions. This medication, containing quetiapine fumarate, is designed for oral administration and is manufactured by Mint Pharmaceuticals Inc. in Canada.

Strength

150 MG

Manufacturer / TM Owner

MINT PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mint-Quetiapine XR 150 mg is commonly used to manage symptoms associated with mental health conditions. It is often prescribed for conditions like schizophrenia or bipolar disorder, where it may help regulate mood and reduce symptoms. The extended-release formulation is designed to provide a steady release of the active ingredient over time, which can help maintain consistent levels in the body.

Side Effects

Common effects of Mint-Quetiapine XR 150 mg may include drowsiness, dizziness, and dry mouth. Some users may also experience weight gain or changes in appetite. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

Mint-Quetiapine XR 150 mg should be handled with care, especially if you have a history of low blood pressure, heart problems, or seizures. It is important to follow the prescribed dosage and administration instructions provided by your healthcare professional. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Mint-Quetiapine XR 150 mg may interact with certain medications, including those that affect the central nervous system, such as alcohol or other sedatives. It is also important to inform your healthcare provider about any other medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Frequently Asked Questions

Mint-Quetiapine XR 150 mg is used to manage symptoms associated with mental health conditions like schizophrenia or bipolar disorder.

Mint-Quetiapine XR 150 mg is an extended-release tablet designed for oral administration. It should be taken as directed by your healthcare provider.

Common side effects may include drowsiness, dizziness, dry mouth, weight gain, and changes in appetite.

It is important to consult your healthcare provider before taking Mint-Quetiapine XR 150 mg with other medications to avoid potential interactions.

Mint-Quetiapine XR 150 mg is manufactured by Mint Pharmaceuticals Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.